Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1818-1821
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1818
Table 1 Age distribution of MEED, PL and EC detected by cytological screening of 16763 persons.
Histology GradeAge
Total
40 yr45 yr50 yr55 yr60 yr65 yr
Normal (case, %)2718 (50.6)1518 (43.8)1094 (39.1)945 (35.6)651 (29.5)95 (30.7)7021
MEED1574 (29.3)1100 (31.7)928 (33.1)882 (33.2)758 (34.9)104 (33.1)5346
PL1056 (19.7)816 (23.6)745 (26.6)782 (29.5)720 (33.2)98 (31.7)4217
EC20 (0.4)29 (0.8)31 (1.1)46 (1.7)41 (1.9)12 (3.9)179
Total5368346327982655217030916763
Table 2 Age distribution by endoscopic pathologic screening of 2013 persons.
Pathology GradeAge
Total
40 yr45 yr50 yr55 yr60 yr65 yr
Normal (case, %)746 (94.2)388 (84.7)239 (74.2)165 (73.3)83 (55.7)33 (49.3)1654
PL43 (5.4)57 (12.4)67 (20.8)39 (17.3)47 (31.5)17 (25.4)270
Early cancer3 (0.4)10 (2.2)11 (3.4)14 (6.2)11 (7.4)8 (11.9)57
Advanced cancer0 (0.0)3 (0.7)5 (1.6)7 (3.1)8 (5.4)9 (13.4)32
Total792458322225149672013
Table 3 Ridit value by histology by age distribution in comparison with standard group.
Age (yr)CasesRidit Value95%CI
45134630.5
4053680.46(0.45-0.47)
5027980.53(0.51-0.54)
5526550.55(0.54-0.56)
6021700.58(0.57-0.59)
653090.59(0.55-0.62)
Total16763
Table 4 Ridit value for endoscopic pathology by age distribution in comparison with standard group.
Age (yr)CasesRidit Value95%CI
4514580.5
407920.45(0.43-0.47)
503220.55(0.52-0.58)
552250.56(0.52-0.60)
601490.65(0.60-0.70)
65670.69(0.62-0.76)
Total2013
Table 5 Average age of each histology grade by cytology screening.
Histology gradeCasesMean±SDt valueP
MEED534650.3±7.567.162<0.001
SEEDI317951.2±7.703.554<0.001
SEED II86651.6±7.544.537<0.001
NEC17252.4±7.145.527<0.001
EC17954.4±7.23
Table 6 Average age of each pathology grade by endoscopic screening and tumor registration.
Pathology gradeCasesMean±SDt valueP
Mild dysplasia17251.6±7.905.250<0.001
Moderate dysplasia15753.5±7.424.22<0.001
Severe dysplasia5351.4±7.264.764<0.001
Early cancer5055.6±7.312.248<0.05
Advanced cancer1926561.7±11.231.086>0.05
Advanced cancer3156.7±6.76